Effects of N-acetyl Cysteine During Primary Percutaneous Coronary Intervention

A phase 3 trial registered on ClinicalTrials.gov. The registry status is active, not recruiting. It enrolled 100 participants.

Also called NCT01878344

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; triple masking; primary purpose diagnostic
Phase
Phase 3
Enrolled
  • 100 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT01878344
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Türkiye (from the registry)
Registry status
  • Active, not recruiting (from the registry)

Technical summary

Registry record NCT01878344. Randomized; triple masking; primary purpose diagnostic. Start 2013-01 (actual); primary completion 2018-01 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Effects of N-acetyl Cysteine During Primary Percutaneous Coronary Intervention
Acronym
EASE-PRM-PCI
Condition
Acute ST Segment Elevation Myocardial Infarction
Intervention (Drug)
NAC
Intervention (Drug)
Saline
Lead sponsor
Suleyman Demirel University (class: other)

Record details

Record id
cardio:ct-nct01878344
Content hash
ed1e422adfbffbeaca2a0519b4b5f22849e4773824a49a3fca65b550e02f5454